Study for patients with stable heart failure of ischemic origin
-
- STATUS
- Recruiting
Summary
We are carrying out a clinical trial with an investigational drug that is being developed with the intention of treating patients with heart failure of ischemic origin (heart failure characterised by a reduced blood supply to the heart).
The main purpose of the study will be to assess how safe the study drug is and to determine how long the study drug will remain in the body. We may also study how the study drug will affect the body.
The information gathered during this clinical trial may be used to support further drug development, including larger trials in patients with heart failure.
In recognition of the time and effort involved in taking part in this study, you will receive £1,692 (£1,027 study payment, £505 bonus and up to £160 for travel expenses) on completion of the study provided you comply fully with all the study requirements.
For more information about this study:
- You may also contact us directly; Azar Alexander-Sefre can be reached via e-mail at a.sefre@richmondpharmacology.com or via phone at +44 (0) 207 042 5800
Description
In recognition of the time and effort involved in taking part in this study, you will receive £1,692 (£1,027 study payment, £505 bonus and up to £160 for travel expenses) on completion of the study provided you comply fully with all the study requirements.
Details
| Condition | Heart Stent, Heart Failure, Heart failure, Stent, Ischemic Heart Failure, Ischemic Heart, Coronary Artery Disease |
|---|---|
| Clinical Study Identifier | TX227267 |
| Last Modified on | 23 November 2020 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer